PDT Partners’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-56,406
| Closed | -$4.5M | – | 1014 |
|
|
2021
Q1 | $4.5M | Sell |
56,406
-4,377
| -7% | -$342K | 0.32% | 86 |
|
|
2020
Q4 | $4.79M | Sell |
60,783
-12,959
| -18% | -$760K | 0.32% | 138 |
|
|
2020
Q3 | $3.24M | Sell |
73,742
-31,558
| -30% | -$1.55M | 0.21% | 166 |
|
|
2020
Q2 | $4.66M | Buy |
105,300
+88,900
| +542% | +$3.32M | 0.32% | 124 |
|
|
2020
Q1 | $589K | Buy |
+16,400
| New | +$933K | 0.05% | 332 |
|
|
2016
Q4 | – | Sell |
-18,050
| Closed | -$1.41M | – | 568 |
|
|
2016
Q3 | $1.41M | Sell |
18,050
-6,600
| -27% | -$479K | 0.08% | 267 |
|
|
2016
Q2 | $1.69M | Buy |
24,650
+8,200
| +50% | +$566K | 0.13% | 213 |
|
|
2016
Q1 | $1.17M | Hold |
16,450
| – | – | 0.07% | 291 |
|
|
2015
Q4 | $1.02M | Sell |
16,450
-13,100
| -44% | -$799K | 0.14% | 207 |
|
|
2015
Q3 | $1.68M | Sell |
29,550
-10,639
| -26% | -$563K | 0.04% | 530 |
|
|
2015
Q2 | $2.16M | Buy |
40,189
+24,639
| +158% | +$1.2M | 0.06% | 402 |
|
|
2015
Q1 | $739K | Buy |
15,550
+3,000
| +24% | +$133K | 0.02% | 883 |
|
|
2014
Q4 | $543K | Buy |
12,550
+2,500
| +25% | +$102K | 0.05% | 440 |
|
|
2014
Q3 | $346K | Hold |
10,050
| – | – | 0.01% | 1068 |
|
|
2014
Q2 | $368K | Buy |
+10,050
| New | +$341K | 0.01% | 1125 |
|
|
2014
Q1 | – | Sell |
-19,145
| Closed | -$649K | – | 1390 |
|
|
2013
Q4 | $649K | Buy |
19,145
+1,344
| +8% | +$46.6K | 0.08% | 322 |
|
|
2013
Q3 | $567K | Sell |
17,801
-907
| -5% | -$24.1K | 0.02% | 999 |
|
|
2013
Q2 | $422K | Buy |
+18,708
| New | +$405K | 0.01% | 1135 |
|
PDT Partners's CMD Position: Q2 2021 in Review
PDT Partners sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 56,406 shares — an estimated $4.5M sold.
PDT Partners first reported a position in CMD in Q2 2013 and held it in 18 quarters. The position peaked at $4.79M in Q4 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- PDT Partners reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- PDT Partners sold 56,406 Cantel Medical Corporation shares in Q2 2021, an estimated $4.5M.
- PDT Partners first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 18 quarters.
- PDT Partners's Cantel Medical Corporation position peaked at $4.79M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on PDT Partners's 13F filing for Q2 2021, filed 16 Aug 2021.